Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by aldo451on Jan 11, 2019 8:03pm
554 Views
Post# 29221752

RE:Fred Dumais

RE:Fred DumaisHe was in San Fran, here is part of his reply I received late this afternnon...

Just back today from SF attending the JP Morgan conference. Very good set of meetings. 3 tracks every day with BD discussions with pharma companies, bankers, analysts and investors. Our interim CEO is extremely focused and dedicated to making sure the partnering process moves as quickly as possible as well as fixing the balance sheet.
 
Yukon78 wrote: Is Fred ansewering anybodies inquiries?


Bullboard Posts